PALB2 and breast cancer: A recent international study from 21 countries that comprised 524 families with PALB2 pathogenic variants (PVs) revealed that the estimated relative risk associated with PALB2 PVs for breast cancer in females was 7.18 (95% CI, 5.82–8.85; p = 6.5 × 10−76).